AI assistant
Sending…
JOHNSON & JOHNSON — Director's Dealing 2012
Dec 11, 2012
29750_dirs_2012-12-10_39b52b47-13e9-496d-87bc-57bcb33887b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2012-12-07
Reporting Person: LINDQUIST SUSAN L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-07 | Common Stock | M | 7600 | $53.93 | Acquired | 22205 | Direct |
| 2012-12-07 | Common Stock | S | 7600 | $70.02 | Disposed | 14605 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-07 | Non-Employee Director Stock Options (Right to Buy) | $53.93 | M | 7600 | Disposed | 2014-02-07 | Common Stock (7600) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Deferred Share Units | $ | Common Stock (0) | 15952 | Direct |
Footnotes
F1: Includes 1,545 shares held under Issuer's Dividend Reinvestment Program.
F2: Awarded under the Stock Option Plan for Non-Employee Directors and exercisable in full one day after the first anniversary of the grant.
F3: The Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).
More from JOHNSON & JOHNSON
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Interim / Quarterly Report
2026
Apr 22
Regulatory Filings
2026
Apr 14
Major Shareholding Notification
2026
Apr 13
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Mar 18